Noninvasive Differentiation of Meningiomas and Dural Metastases Using Intratumoral Vascularity Obtained by Arterial Spin Labeling.
Adult
Aged
Aged, 80 and over
Contrast Media
Diagnosis, Differential
Dura Mater
/ diagnostic imaging
Female
Humans
Image Processing, Computer-Assisted
Magnetic Resonance Angiography
/ methods
Male
Meningeal Neoplasms
/ diagnostic imaging
Meningioma
/ diagnostic imaging
Middle Aged
Neoplasm Metastasis
Prospective Studies
Spin Labels
Brain metastases
Extra-axial brain tumors
Intratumoral neovascularization
Meningioma
Pulsed arterial spin labeling
Journal
Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
05
07
2018
accepted:
06
06
2019
pubmed:
3
7
2019
medline:
8
6
2021
entrez:
3
7
2019
Statut:
ppublish
Résumé
Using conventional magnetic resonance imaging (MRI) techniques, the imaging features of meningiomas and dural metastases overlap and a differentiation between these tumor entities therefore remains difficult, particularly in patients with a known primary neoplasm. The purpose of this study was to explore the potential role of normalized vascular intratumoral signal intensity values (nVITS) obtained from pulsed arterial spin labeling (PASL) to differentiate between meningiomas and dural metastases. In this study PASL was performed in 46 patients with meningiomas (n = 30) and dural metastases (n = 16) on a 3T scanner, in addition to the routine diagnostic imaging protocol. The ratio between the vascular signal intensity of the tumor and the contralateral normal white matter obtained by PASL images was defined as nVITS. Meningiomas showed significantly higher nVITS values compared to dural metastases (p < 0.001). The optimal nVITS cut-off value to differentiate between the 2 tumor entities was 1.989, with 100% sensitivity and 81.2% specificity. The nVITS values obtained by PASL provide a fast and noninvasive MRI technique with which to differentiate between meningiomas and dural metastases in a routine clinical setting based on tumor vascularity.
Identifiants
pubmed: 31263906
doi: 10.1007/s00062-019-00808-x
pii: 10.1007/s00062-019-00808-x
pmc: PMC7471110
doi:
Substances chimiques
Contrast Media
0
Spin Labels
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
599-605Références
Clin Neuroradiol. 2017 Jun;27(2):135-144
pubmed: 28466126
J Neurooncol. 2009 Nov;95(2):281-284
pubmed: 19449147
NMR Biomed. 1997 Jun-Aug;10(4-5):237-49
pubmed: 9430354
Magn Reson Med. 2011 Jan;65(1):120-7
pubmed: 20740655
Br J Cancer. 1953 Dec;7(4):438-48
pubmed: 13126386
AJNR Am J Neuroradiol. 2014 Mar;35(3):482-9
pubmed: 23945226
J Neurooncol. 2011 Jul;103(3):777-83
pubmed: 21061142
Acta Radiol. 2008 May;49(4):450-7
pubmed: 18415790
Eur Radiol. 2003 Mar;13(3):582-91
pubmed: 12594562
J Neurooncol. 2009 Dec;95(3):401-411
pubmed: 19562257
Ann Oncol. 2017 Jul 1;28(suppl_4):iv84-iv99
pubmed: 28881917
Clin Neuroradiol. 2015 Sep;25(3):281-9
pubmed: 24828225
Lancet Oncol. 2016 Sep;17(9):e383-91
pubmed: 27599143
Eur J Radiol. 2014 May;83(5):806-10
pubmed: 24613549
Neuroradiology. 2004 Aug;46(8):642-8
pubmed: 15232661
Int J Surg Case Rep. 2015;15:63-5
pubmed: 26318129
Neuroradiology. 2003 Jan;45(1):44-9
pubmed: 12525954
J Clin Neurosci. 2004 Sep;11(7):780-3
pubmed: 15337150
Insights Imaging. 2014 Feb;5(1):113-22
pubmed: 24399610
Cancer. 2009 May 1;115(9):1947-53
pubmed: 19241421
Magn Reson Med. 1999 Jun;41(6):1246-54
pubmed: 10371458
Neuro Oncol. 1999 Jan;1(1):14-25
pubmed: 11554386
AJNR Am J Neuroradiol. 2011 Dec;32(11):2073-9
pubmed: 21960503
AJR Am J Roentgenol. 1994 Jul;163(1):181-6
pubmed: 8010210
AJNR Am J Neuroradiol. 2008 Aug;29(7):1228-34
pubmed: 18372417
Neuro Oncol. 2015 Oct;17 Suppl 4:iv1-iv62
pubmed: 26511214
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931